Handbook of Clinical medicine

should be given. __OOHHCCMM__1100ee..iinnddbb 441188 0022//0055//22001177 1199::0077 sesaesid suoitcefnI Non-falciparum malaria 419 P. vivax, P. ovale, P. malariae, P. knowlesi: • If mixed infection with falciparum, treat as falciparum. • If severe/complicated non-falciparum disease, treat as severe falciparum. • If uncomplicated disease, treat with ACT as uncomplicated falciparum. Chloroquine can be used for non-falciparum disease. Dosing in adult: 620mg base at 0h, 310mg base at 6–8h, 310mg base on day 2 and 3. But: • do not use if P. falciparum cannot be excluded • be aware that ACT may work more quickly on both fever and parasite count • chloroquine resistance exists in P. vivax (Papua New Guinea, Indonesia). In addition to other treatment, P. vivax and P. ovale require eradication of liver hypnozoites with primaquine: • P. vivax: adult 30mg (0.5mg/kg) daily for 14d. • P. ovale: adult 15mg (0.25mg/kg) daily for 14d. Risk of haemolysis with primaquine in G6PD defi ciency so screen prior to use. Seek expert advice for dosing/monitoring patients with G6PD defi ciency, and in pregnancy. Malaria prevention Vector control for all people at risk of malaria. Includes: • Source reduction by destruction of mosquito breeding sites (ie standing water). • Long-lasting insecticidal nets.
